ТОО "CAPITOL" (КАПИТОЛЬ)
This is a company preview
Unlock the full report for 1 check — contacts, bank accounts, court cases, government contracts, arrests, licenses and PDF export.
Risks
1/18Комитет государственных доходов · Государственные закупки РК · АО ФНБ «Самрук-Казына» · АОО «НИШ»Комитет государственных доходов · data as of 11.11.2026
This assessment is informational and analytical only, based on our internal methodology and open sources; it is not an official government conclusion or a guarantee of reliability.
Procurement signals
Court cases
Arrests & encumbrances
Enforcement proceedings
Certificates
Licenses and permits
Summary
Министерство юстиции РКActivities
1ОКЭДПроизводство основных фармацевтических продуктов
Contacts
Change history
Financial statements
PremiumPublic contracts
What it sells and where
Samruk-Kazyna procurement
Tender bids
Procurement as a customer
Assets
Bank accounts
Leadership
2- СУ
Сарсембаева Умсынкуль Дуйсенбековна
Director
Former directors
- СТСАРСЕМБАЕВ ТИМУР МАРАТОВИЧ
Founders
Accreditations
Employees
Affiliated companies
PremiumDirector's involvement in other legal entities
Branches
Company networks
PremiumSimilar companies
Media mentions
Company summary
ТОО "CAPITOL" (КАПИТОЛЬ) (BIN 110740016182): Liquidated legal entity, Astana, registered in 2011. Main activity: manufacture of pharmaceutical products. Small enterprise, headcount: up to 5 employees. Screening flagged 1 risk indicator: liquidated according to the tax authority. Date of the last change record: April 1, 2022 (change of director). Founders: 1. Director on record: Сарсембаева Умсынкуль Дуйсенбековна. Per the registry as of June 11, 2026.
Data sources and disclaimer
Sources: Министерство юстиции РК, Комитет государственных доходов МФ РК, Верховный Суд РК, Портал государственных закупок РК, АО «Самрук-Казына», Бюро национальной статистики РК, Портал электронного лицензирования. Data is collected automatically and may lag behind primary sources; the absence of a record does not guarantee the absence of the fact. This is reference information and does not replace an official extract. Methodology: SafeDeal editorial policy.